Letter by Johnson et al regarding article, "Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry"

Circ Cardiovasc Interv. 2013 Apr;6(2):e26. doi: 10.1161/CIRCINTERVENTIONS.112.000016.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antithrombins / therapeutic use*
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Male
  • Myocardial Infarction / therapy*
  • Peptide Fragments / therapeutic use*
  • Percutaneous Coronary Intervention*

Substances

  • Antithrombins
  • Fibrinolytic Agents
  • Peptide Fragments